SILK [NASD]
Silk Road Medical, Inc
Index- P/E- EPS (ttm)-1.54 Insider Own2.00% Shs Outstand37.63M Perf Week0.36%
Market Cap1.71B Forward P/E- EPS next Y-1.32 Insider Trans-29.83% Shs Float37.13M Perf Month-21.09%
Income-55.00M PEG- EPS next Q-0.40 Inst Own99.80% Short Float / Ratio6.02% / 4.84 Perf Quarter-24.40%
Sales138.60M P/S12.33 EPS this Y-6.90% Inst Trans-0.54% Short Interest2.24M Perf Half Y-5.69%
Book/sh4.35 P/B9.56 EPS next Y12.00% ROA-29.80% Target Price56.20 Perf Year5.91%
Cash/sh5.20 P/C8.00 EPS next 5Y16.20% ROE-63.10% 52W Range27.30 - 58.04 Perf YTD-21.29%
Dividend- P/FCF- EPS past 5Y-19.10% ROI-21.90% 52W High-28.33% Beta1.25
Dividend %- Quick Ratio9.60 Sales past 5Y57.60% Gross Margin72.70% 52W Low52.38% ATR2.46
Employees414 Current Ratio10.40 Sales Q/Q41.70% Oper. Margin-37.60% RSI (14)33.28 Volatility6.56% 4.87%
OptionableYes Debt/Eq0.46 EPS Q/Q20.30% Profit Margin-39.70% Rel Volume0.00 Prev Close41.60
ShortableYes LT Debt/Eq0.46 EarningsFeb 28 AMC Payout- Avg Volume461.74K Price41.60
Recom2.00 SMA20-11.35% SMA50-17.75% SMA200-9.80% Volume0 Change0.00%
Mar-10-23Upgrade Citigroup Sell → Neutral $50
Feb-07-23Downgrade Wolfe Research Outperform → Peer Perform
Nov-22-22Initiated BofA Securities Buy $60
Jul-11-22Downgrade Citigroup Neutral → Sell $33
Apr-06-22Initiated Wolfe Research Outperform $48
Nov-19-21Upgrade Citigroup Sell → Neutral $50
Oct-01-21Downgrade Citigroup Neutral → Sell $50
Oct-01-20Downgrade Citigroup Buy → Neutral $58 → $71
Aug-21-20Initiated Piper Sandler Neutral $54
Jul-09-20Initiated SVB Leerink Outperform $51
Show Previous Ratings
Mar-02-23 08:29PM
Mar-01-23 07:52AM
Feb-28-23 08:05PM
04:05PM
Feb-07-23 09:00AM
12:00PM Loading…
Jan-23-23 12:00PM
Jan-09-23 07:20AM
07:05AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
04:05PM Loading…
04:05PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
04:25PM
12:53PM
Sep-29-22 07:41AM
Sep-28-22 02:25PM
Sep-07-22 04:15PM
Aug-30-22 04:15PM
Jul-27-22 09:31AM
Jul-26-22 05:35PM
04:05PM Loading…
04:05PM
Jul-22-22 01:26PM
Jul-12-22 04:15PM
07:07AM
Jun-15-22 09:00AM
Jun-09-22 02:29PM
Jun-02-22 07:00AM
May-31-22 09:00AM
May-10-22 11:21AM
May-04-22 07:35PM
04:05PM
May-02-22 08:30AM
Apr-26-22 04:10PM
Apr-13-22 04:15PM
Feb-24-22 05:40PM
04:01PM
08:12AM
Feb-17-22 03:03PM
Feb-03-22 04:30PM
Feb-02-22 04:30PM
Jan-27-22 10:00AM
Jan-10-22 01:11PM
Jan-07-22 05:38PM
Dec-30-21 04:30PM
Nov-25-21 09:11AM
Nov-16-21 12:22PM
Nov-10-21 04:10PM
12:31AM
Nov-09-21 06:45PM
04:05PM
Nov-03-21 11:34AM
Nov-02-21 04:10PM
03:01PM
Nov-01-21 11:38AM
Oct-21-21 04:10PM
Oct-13-21 11:42AM
Oct-11-21 03:39PM
Oct-06-21 11:30AM
Sep-30-21 11:15AM
08:50AM
Sep-29-21 12:00PM
Sep-15-21 10:50AM
Sep-01-21 04:10PM
Aug-18-21 04:15PM
Jul-30-21 01:32AM
Jul-29-21 06:35PM
04:05PM
Jul-26-21 04:05PM
Jul-22-21 03:03PM
Jul-20-21 09:47AM
Jul-16-21 04:05PM
Jul-06-21 04:05PM
Jun-22-21 04:05PM
May-17-21 01:17PM
May-12-21 07:16AM
May-10-21 12:51PM
May-05-21 03:00AM
May-04-21 07:20PM
04:05PM
02:30PM
May-03-21 04:05PM
Apr-20-21 04:05PM
Apr-15-21 04:05PM
Apr-02-21 12:11PM
Mar-25-21 09:42AM
07:08AM
Mar-10-21 09:00AM
06:20AM
Mar-02-21 10:00AM
Mar-01-21 06:45PM
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WEATHERMAN ELIZABETH HDirectorMar 15Sale41.915,000209,550149,454Mar 17 07:06 PM
Rogers Erica J.President and CEOMar 13Option Exercise1.606,0009,600275,132Mar 15 06:16 PM
Rogers Erica J.President and CEOMar 13Sale42.236,000253,393269,132Mar 15 06:16 PM
Davis Andrew S.Chief Commercial OfficerMar 06Sale47.743,868184,653115,683Mar 06 08:19 PM
Ruedy RichardEVPClin&Reg.Affairs&QAMar 06Sale47.732,373113,257145,483Mar 06 08:20 PM
Rogers Erica J.President and CEOMar 03Sale47.1018,043849,901269,132Mar 06 08:14 PM
Buchanan Lucas W.COO/CFOMar 03Sale47.119,918467,193205,575Mar 06 08:17 PM
Davis Andrew S.Chief Commercial OfficerMar 01Option Exercise4.736,75331,942104,144Mar 02 09:01 PM
Davis Andrew S.Chief Commercial OfficerMar 01Sale48.026,753324,27298,205Mar 02 09:01 PM
WEATHERMAN ELIZABETH HDirectorFeb 15Sale49.865,000249,300154,454Feb 17 06:56 PM
Rogers Erica J.President and CEOFeb 13Option Exercise1.606,0009,600252,199Feb 15 06:18 PM
Rogers Erica J.President and CEOFeb 13Sale50.946,000305,627246,199Feb 15 06:18 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Option Exercise4.736,75331,942104,958Feb 03 07:19 PM
Chou Tony M.DirectorFeb 01Sale55.0013,008715,44075,707Feb 03 07:14 PM
Davis Andrew S.Chief Commercial OfficerFeb 01Sale54.056,753365,00098,205Feb 03 07:19 PM
Buchanan Lucas W.COO/CFOJan 19Option Exercise13.9038,528535,666217,289Jan 19 08:01 PM
Buchanan Lucas W.COO/CFOJan 19Sale53.4041,2442,202,533188,811Jan 19 08:01 PM
Buchanan Lucas W.COO/CFOJan 17Option Exercise1.6045,00072,000236,527Jan 19 08:01 PM
WEATHERMAN ELIZABETH HDirectorJan 17Sale54.6956,3553,082,224159,454Jan 19 06:44 PM
Buchanan Lucas W.COO/CFOJan 17Sale54.6845,0002,460,622191,527Jan 19 08:01 PM
Chou Tony M.DirectorJan 13Sale55.0080644,33087,709Jan 17 06:07 PM
Chou Tony M.DirectorJan 12Sale55.0020011,00088,515Jan 17 06:07 PM
Rogers Erica J.President and CEOJan 11Option Exercise1.606,0009,600252,199Jan 13 05:32 PM
Rogers Erica J.President and CEOJan 11Sale51.536,000309,180246,199Jan 13 05:32 PM
Davis Andrew S.Chief Commercial OfficerJan 03Option Exercise2.336,75315,744103,380Jan 04 08:03 PM
Davis Andrew S.Chief Commercial OfficerJan 03Sale52.876,753357,03198,205Jan 04 08:03 PM
Buchanan Lucas W.COO/CFODec 15Option Exercise1.6015,00024,000191,527Dec 15 08:35 PM
Buchanan Lucas W.COO/CFODec 13Option Exercise1.6025,00040,000201,527Dec 15 08:35 PM
Buchanan Lucas W.COO/CFODec 13Sale55.0025,0001,375,000176,527Dec 15 08:35 PM
Chou Tony M.DirectorDec 13Sale55.0010,060553,30088,715Dec 15 07:00 PM
Rogers Erica J.President and CEODec 12Option Exercise1.6010,00016,000256,199Dec 14 07:04 PM
Rogers Erica J.President and CEODec 12Sale53.8510,000538,501246,199Dec 14 07:04 PM
Davis Andrew S.Chief Commercial OfficerDec 01Option Exercise1.556,75310,457102,472Dec 02 06:40 PM
Davis Andrew S.Chief Commercial OfficerDec 01Sale53.006,753357,90998,205Dec 02 06:40 PM
Buchanan Lucas W.COO/CFONov 11Option Exercise1.6024,80039,680201,327Nov 14 06:24 PM
Rogers Erica J.President and CEONov 11Option Exercise1.6010,00016,000256,199Nov 14 06:27 PM
Buchanan Lucas W.COO/CFONov 11Sale50.0024,8001,240,000176,527Nov 14 06:24 PM
Rogers Erica J.President and CEONov 11Sale50.0310,000500,309246,199Nov 14 06:27 PM
Buchanan Lucas W.COO/CFONov 09Option Exercise1.60200320176,727Nov 14 06:24 PM
Buchanan Lucas W.COO/CFONov 09Sale50.0020010,000176,527Nov 14 06:24 PM
Davis Andrew S.Chief Commercial OfficerNov 01Option Exercise1.466,7539,859104,958Nov 01 07:48 PM
Davis Andrew S.Chief Commercial OfficerNov 01Sale44.176,753298,28098,205Nov 01 07:48 PM
Rogers Erica J.President and CEOOct 11Option Exercise1.6010,00016,000256,199Oct 13 06:58 PM
Rogers Erica J.President and CEOOct 11Sale42.3210,000423,218246,199Oct 13 06:58 PM
Davis Andrew S.Chief Commercial OfficerOct 03Option Exercise1.466,7539,859104,958Oct 05 08:36 PM
Davis Andrew S.Chief Commercial OfficerOct 03Sale44.766,753302,26498,205Oct 05 08:36 PM
WEATHERMAN ELIZABETH HDirectorSep 15Sale42.455,000212,250210,809Sep 19 06:34 PM
Rogers Erica J.President and CEOSep 12Option Exercise1.6010,00016,000256,199Sep 14 07:51 PM
Rogers Erica J.President and CEOSep 12Sale43.6210,000436,173246,199Sep 14 07:51 PM
Davis Andrew S.Chief Commercial OfficerSep 01Option Exercise1.466,7539,859104,958Sep 02 05:40 PM
Davis Andrew S.Chief Commercial OfficerSep 01Sale38.936,753262,89498,205Sep 02 05:40 PM
Buchanan Lucas W.COO/CFOAug 15Option Exercise20.0012,355247,100204,119Aug 17 05:32 PM
Buchanan Lucas W.COO/CFOAug 15Sale48.4625,0001,211,508179,119Aug 17 05:32 PM
WEATHERMAN ELIZABETH HDirectorAug 15Sale47.255,000236,250215,809Aug 17 05:33 PM
Buchanan Lucas W.COO/CFOAug 12Sale47.7925,0001,194,722191,764Aug 12 08:45 PM
Rogers Erica J.President and CEOAug 11Option Exercise1.6010,00016,000256,199Aug 15 06:30 PM
Buchanan Lucas W.COO/CFOAug 11Sale48.6025,0001,215,105216,764Aug 12 08:45 PM
Rogers Erica J.President and CEOAug 11Sale48.6010,000485,957246,199Aug 15 06:30 PM
Buchanan Lucas W.COO/CFOAug 10Option Exercise8.0117,464139,887255,930Aug 12 08:45 PM
Buchanan Lucas W.COO/CFOAug 10Sale47.0325,0001,175,655241,764Aug 12 08:45 PM
WEATHERMAN ELIZABETH HDirectorJul 21Sale41.915,000209,550229,454Jul 25 06:00 PM
Rogers Erica J.President and CEOJul 11Option Exercise1.6030,00048,000275,649Jul 13 05:32 PM
Rogers Erica J.President and CEOJul 11Sale40.4430,0001,213,194245,649Jul 13 05:32 PM
WEATHERMAN ELIZABETH HDirectorJul 08Sale41.9110,000419,100234,454Jul 11 07:09 PM
Rogers Erica J.President and CEOApr 11Option Exercise1.6030,00048,000275,649Apr 13 07:21 PM
Rogers Erica J.President and CEOApr 11Sale43.3730,0001,301,172245,649Apr 13 07:21 PM